The standard PCR kits are used for the qualitative detection of nucleic acids of Mpox Virus in blood and rash exudate from individuals who are suspected of having contracted Mpox Virus by their healthcare provider. The lyophilized type enables further detection in human tonsillar and nasopharyngeal swabs. Both are indicated for use as aids in the diagnosis and monitoring of Mpox Virus infection.

According to the principles of fluorescence PCR technology, the kits are designed with specific primers and Taqman probes for Mpox Virus, and detect the nucleic acid of Mpox Virus through fluorescence PCR detector. These kits are equipped with an internal reference control to monitor sample collection, preservation and transportation, as well as nucleic acid extraction, to avoid false negative results.

Both types of the virus detection kits are CE-marked for sale in Europe. The non-lysophilized tests perform with a sensitivity of 96.7% and specificity of 93.72%, with the ability to deliver results in under 70 minutes.